Pricing pressures and Middle East unrest hit GSK profits

Article Date: 26/04/2012 07:45
Pricing pressures and Middle East unrest hit GSK profits

Vacancy Search

Quick job search

Advanced Search

Latest News

11 pharma firms in Romanian bribery probe

11 pharma firms in Romanian bribery probe

BMS in new Opdivo combo collaboration

BMS in new Opdivo combo collaboration

Daiichi rare cancer drug shows promise

Daiichi rare cancer drug shows promise

GSK sales rise, but new bribery allegations emerge

GSK sales rise, but new bribery allegations emerge

Eisai's Lenvima breakthrough therapy for new indication

Eisai's Lenvima breakthrough therapy for new indication

Sanofi diabetes combo meets Phase III goal

Sanofi diabetes combo meets Phase III goal

Merck acquires immune-oncology specialist cCAM

Merck acquires immune-oncology specialist cCAM

Trio of Novartis castoffs is just the beginning for Mereo

Novartis might have deemed BPS804, BCT197 and BGS649 excess to requirements, but the trio of phase II assets has given life to a brand new UK biotech company, Mereo Biopharma, launched today...

Sanofi dengue vaccine shows promise in older children

Sanofi dengue vaccine shows promise in older children

Sanofi and Regeneron look to break into immunotherapy

Sanofi and Regeneron look to break into immunotherapy
more news